No difference in the effect of biperiden and amantadine on negative symptoms in medicated chronic schizophrenic patients.
Silver
H
H
Flugelman (Mazra) Psychiatric Hospital, Doar Na Ashrat, Israel.
Geraisy
N
N
D000328:Adult; D000547:Amantadine / Q000009:adverse effects* / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000188:drug therapy; D001712:Biperiden / Q000009:adverse effects* / Q000627:therapeutic use; D002908:Chronic Disease; D018592:Cross-Over Studies; D015259:Dopamine Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D010276:Parasympatholytics / Q000009:adverse effects* / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy; D012565:Schizophrenic Psychology
D015259:Dopamine Agents; D010276:Parasympatholytics; D001712:Biperiden; D000547:Amantadine